Encompass Health Corp.
- EHC · NYSE
- Services-Hospitals
- Birmingham, AL
- 42,000 employees
- CIK 0000785161
Updated from SEC filings through
Top things to know
Executives
- Mark Tarr President and Chief Executive Officer 8-K, 2026-10-28
- Mark J. Tarr President & CEO 4, 2026-08-11
- Douglas E. Coltharp EVP & Chief Financial Officer 4, 2026-08-11
- Andrew L. Price Chief Accounting Officer 4, 2026-09-01
- Patrick William Tuer EVP, Chief Operating Officer 4, 2026-05-12
- Elissa Joy Charbonneau Chief Medical Officer 4, 2026-03-03
What leadership is saying
“We are very pleased with our performance for the third quarter, with revenue increasing 8.9% and Adjusted EBITDA growing 15.5%”
Earnings press release (8-K Ex. 99.1), filed October 28, 2026
Encompass Health Corp is a U.S. public company in services-hospitals (SIC 8060), headquartered in Birmingham, AL. It trades as EHC on NYSE. Revenue was $5.9B in the fiscal year ending December 31, 2025, +10.5% from the year before. It reported about 42,000 employees. Mark Tarr is President and Chief Executive Officer.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.9B 10-K, 2026-02-26 | $5.4B 10-K, 2026-02-26 | $4.8B 10-K, 2026-02-26 | $4.3B 10-K, 2025-02-28 | $4.0B 10-K, 2024-02-28 |
| Operating income | Not on file | Not on file | Not on file | $540M 10-K, 2023-02-27 | $560M 10-K, 2023-02-27 |
| SG&A | $236M 10-K, 2026-02-26 | $209M 10-K, 2026-02-26 | $202M 10-K, 2026-02-26 | $154M 10-K, 2025-02-28 | $170M 10-K, 2024-02-28 |
| Net income | $566M 10-K, 2026-02-26 | $456M 10-K, 2026-02-26 | $352M 10-K, 2026-02-26 | $271M 10-K, 2025-02-28 | $412M 10-K, 2024-02-28 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Mark Tarr | President and Chief Executive Officer | 8-K, 2026-10-28 |
| Mark J. Tarr President and Chief Executive Officer at Encompass Health | President & CEO | 4, 2026-08-11 |
| Douglas E. Coltharp | EVP & Chief Financial Officer | 4, 2026-08-11 |
| Andrew L. Price | Chief Accounting Officer | 4, 2026-09-01 |
| Patrick William Tuer | EVP, Chief Operating Officer | 4, 2026-05-12 |
| Edmund M. Fay SVP, Treasurer at Encompass Health Corporation | Named in proxy bio: Senior Vice President and Treasurer | DEF 14A, 2026-04-07 |
| Elissa J. Charbonneau, D.O. Chief Medical Officer at Encompass Health | Named in proxy bio: Chief Medical Officer | DEF 14A, 2026-04-07 |
| Patrick W. Tuer EVP, Chief Operating Officer at Encompass Health | Named in proxy bio: Executive Vice President and Chief Operating Officer | DEF 14A, 2026-04-07 |
| Patrick Darby | Named in proxy bio: Executive Vice President, General Counsel and Secretary | DEF 14A, 2026-04-07 |
| Elissa Joy Charbonneau | Chief Medical Officer | 4, 2026-03-03 |
| John Patrick Darby | EVP, Gen Counsel & Secretary | 4, 2026-09-01 |
 Cain A. Hayes | Board member (per proxy) bio: Member of Compensation and Human Capital Committee and Compliance and Quality of Care Committee | DEF 14A, 2026-04-07 |
 Christopher R. Reidy | Board member (per proxy) bio: Member of Audit Committee (Chair) and Compliance and Quality of Care Committee | DEF 14A, 2026-04-07 |
 Joan E. Herman | Board member (per proxy) bio: Member of Compensation and Human Capital Committee and Compliance and Quality of Care Committee | DEF 14A, 2026-04-07 |
 Kevin J. O'Connor | Board member (per proxy) bio: Member of Compensation and Human Capital Committee (chair) and Nominating/Corporate Governance Committee | DEF 14A, 2026-04-07 |
 Leslye G. Katz | Board member (per proxy) bio: Member of Audit Committee and Nominating/Corporate Governance Committee (Chair) | DEF 14A, 2026-04-07 |
What Encompass Health Corp does
We are the nation’s largest owner and operator of inpatient rehabilitation hospitals in terms of patients treated, revenues, and number of hospitals. We provide specialized rehabilitative treatment, using advanced technology and intensive therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence and quality of life. We operate hospitals in 39 states and Puerto Rico, with concentrations in Florida and Texas. As of December 31, 2025, we operated 173 inpatient rehabilitation hospitals.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 98.1 million (as of October 22, 2026) | 10-Q, November 3, 2026 |
|---|---|---|
| Public float | $12.2B (as of June 30, 2025) | 10-K, February 26, 2026 |
| Reportable segments | 1 (period ending September 30, 2026) | 10-Q, November 3, 2026 |
| Latest proxy statement | Meeting May 7, 2026 (filed April 7, 2026) | DEF 14A, April 7, 2026 |
| Auditor | PricewaterhouseCoopers LLP (Birmingham, Alabama) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| August 31, 2026 | Andrew L. Price Chief Accounting Officer | Sale | 5,211 | $630K | Form 4, September 1, 2026 |
| August 31, 2026 | John Patrick Darby EVP, Gen Counsel & Secretary | Sale | 4,858 | $588K | Form 4, September 1, 2026 |
| August 10, 2026 | Douglas E. Coltharp EVP & Chief Financial Officer | Sale | 18,869 | $2.4M | Form 4, August 11, 2026 |
| August 10, 2026 | Mark J. Tarr President & CEO | Sale | 173,148 | $21.7M | Form 4, August 11, 2026 |
| August 10, 2026 | John Patrick Darby EVP, Gen Counsel & Secretary | Sale | 8,906 | $1.1M | Form 4, August 11, 2026 |
| May 15, 2026 | Douglas E. Coltharp EVP & Chief Financial Officer | Sale | 27,694 | $3.0M | Form 4, May 18, 2026 |
| May 11, 2026 | Patrick William Tuer EVP, Chief Operating Officer | Sale | 682 | $71K | Form 4, May 12, 2026 |
| March 9, 2026 | Edmund Fay Sr. Vice Pres. and Treasurer | Sale | 11,937 | $1.3M | Form 4, March 10, 2026 |
Recent 8-K events
- 8-K filed 2026-11-06
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-10-28
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-13
- Item 8.01 Other events
- 8-K filed 2026-08-05
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-06-01
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- 8-K filed 2026-05-15
- Item 1.01 Entry into a material definitive agreement
- Item 8.01 Other events
- 8-K filed 2026-05-11
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-04-30
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-03-10
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- 8-K filed 2026-02-05
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
Frequently asked questions about Encompass Health Corp
- What does Encompass Health Corp do?
- In its own words, from Item 1 of its 10-K: "We are the nation’s largest owner and operator of inpatient rehabilitation hospitals in terms of patients treated, revenues, and number of hospitals. We provide specialized rehabilitative treatment, using advanced technology and intensive therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence and quality of life. We operate hospitals in 39 states and Puerto Rico, with concentrations in Florida and Texas. As of December 31, 2025, we operated 173 inpatient rehabilitation hospitals."
- What is Encompass Health Corp's revenue?
- $5.9B for the fiscal year ending December 31, 2025, from its 10-K filed February 26, 2026.
- Is Encompass Health Corp profitable?
- Encompass Health Corp reported net income of $566M for the fiscal year ending December 31, 2025.
- How many employees does Encompass Health Corp have?
- About 42,000 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Encompass Health Corp?
- Mark Tarr, President and Chief Executive Officer, as named in a 8-K filed October 28, 2026.
- Who is the CFO of Encompass Health Corp?
- Douglas E. Coltharp, EVP & Chief Financial Officer, as named in a 4 filed August 11, 2026.
- Where is Encompass Health Corp headquartered?
- Birmingham, AL.
- What is Encompass Health Corp's stock ticker?
- EHC on NYSE.
- What industry is Encompass Health Corp in?
- Services-Hospitals, SIC code 8060.
- What is Encompass Health Corp's website?
- encompasshealth.com.
- When does Encompass Health Corp report earnings next?
- November 10, 2026. Source: estimate_8k_pattern.
- Is Encompass Health Corp a public company?
- Yes. Encompass Health Corp files with the SEC under CIK 0000785161 and trades as EHC.
- Who audits Encompass Health Corp?
- PricewaterhouseCoopers LLP, Birmingham, Alabama, as named in its latest annual report (10-K).
- How many shares of Encompass Health Corp are outstanding?
- 98.1 million shares as of October 22, 2026, from its 10-Q filed November 3, 2026.
- What is Encompass Health Corp's public float?
- $12.2B as of June 30, 2025, as reported on the cover of its 10-K filed February 26, 2026.
- How many business segments does Encompass Health Corp report?
- 1 reportable segment for the period ending September 30, 2026, from its 10-Q filed November 3, 2026.
- When is Encompass Health Corp's annual shareholder meeting?
- May 7, 2026, per its proxy statement (DEF 14A) filed April 7, 2026.
- Have Encompass Health Corp insiders traded stock recently?
- Since August 27, 2025, officers and directors reported 11 open-market sales worth about $47.9M and 0 purchases on Forms 4 and 5. The most recent: Andrew L. Price (Chief Accounting Officer) sold 5,211 shares on August 31, 2026.